Product Information
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1327 per EA under NDC 59746079801. Its NADAC has been published 42 times since Sep 10, 2025.
Strength
.5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746079801
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090802On Market Since
11/30/2024
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has been published 42 times since Sep 10, 2025, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1327 per EA |
|---|---|
| All-time high | $0.1744 (Oct 15, 2025) |
| All-time low | $0.1327 (Jun 17, 2026) |
| 52-week high | $0.1744 |
| 52-week low | $0.1327 |
| Median price | $0.1545 |
| Average price | $0.1556 |
| Largest weekly change | -9.4% (Jun 17, 2026) |
| Weeks tracked | 42 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1327 per EA (NDC 59746079801), effective Jun 24, 2026.
How has the price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has declined 21.5%. It has been tracked across 42 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Sep 10, 2025, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1327 (Jun 17, 2026) to a high of $0.1744 (Oct 15, 2025), with a median of $0.1545 per EA.
Are there cheaper alternatives to TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 59746079801) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification